Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Net Income towards Common Stockholders (2016 - 2026)

Ani Pharmaceuticals' Net Income towards Common Stockholders history spans 15 years, with the latest figure at $27.5 million for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 357.35% to $27.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $77.2 million, a 483.08% increase, with the full-year FY2025 number at $77.2 million, up 483.08% from a year prior.
  • Net Income towards Common Stockholders hit $27.5 million in Q4 2025 for Ani Pharmaceuticals, up from $26.3 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for ANIP hit a ceiling of $27.5 million in Q4 2025 and a floor of -$24.6 million in Q3 2024.
  • Historically, Net Income towards Common Stockholders has averaged -$906600.0 across 5 years, with a median of -$1.3 million in 2021.
  • Biggest five-year swings in Net Income towards Common Stockholders: crashed 25451.85% in 2022 and later skyrocketed 1623.23% in 2024.
  • Tracing ANIP's Net Income towards Common Stockholders over 5 years: stood at -$24.3 million in 2021, then skyrocketed by 80.88% to -$4.6 million in 2022, then skyrocketed by 116.11% to $749000.0 in 2023, then plummeted by 1526.17% to -$10.7 million in 2024, then soared by 357.35% to $27.5 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for ANIP at $27.5 million in Q4 2025, $26.3 million in Q3 2025, and $8.1 million in Q2 2025.